✦ LIBER ✦

The safety evaluation of adjuvants during vaccine development: The AS04 experience

✍ Scribed by Nathalie Garçon; Lawrence Segal; Fernanda Tavares; Marcelle Van Mechelen

Book ID: 116963755
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 399 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.04.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mode of Action (MoA) studies contribute

Mode of Action (MoA) studies contribute to the safety evaluation of AS04 adjuvanted vaccines

✍ S. Preiss; M. Mergaerts; A. Di Pasquale; N. Garcon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Development of an AS04-Adjuvanted HPV Va

Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

✍ Garçon, Nathalie; Morel, Sandra; Didierlaurent, Arnaud; Descamps, Dominique; Wet 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 289 KB

Evaluation of the Effectiveness and Safe

Evaluation of the Effectiveness and Safety of Chitosan Derivatives as Adjuvants for Intranasal Vaccines

✍ Kobayashi, Takashi; Fukushima, Kenji; Sannan, Takanori; Saito, Noriko; Takiguchi 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 645 KB

The development and use of vaccine adjuv

The development and use of vaccine adjuvants

✍ Robert Edelman 📂 Article 📅 2002 🏛 Humana Press Inc 🌐 English ⚖ 168 KB

Safety and Immunogenicity of the HPV-16/

Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls

✍ Doris M. Rivera Medina; Alejandra Valencia; Alet de Velasquez; Li-Min Huang; Rom 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Evaluation of inflammation biomarkers fo

Evaluation of inflammation biomarkers for safety assessment of vaccines and adjuvants in the rabbit

✍ M. Watzinger; A. Nguyen; F. Gervais; T. Lemarchand; J. Legrand; J. Descotes 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 90 KB